Abstract
This study examined the correlation between nitric oxide (NO) metabolites in the three major body fluid compartments and assessed performance of newly described vanadium-based assay for simultaneous detection of nitrite and nitrate (NOx) in human samples. Vanadium reduces nitrate to nitrite, which can be measured after a colorimetric reaction with Griess reagents. Cisternal cerebro spinal fluid (CSF), serum and urine samples from 10 patients with acute brain injury (ABI) were compared to control subjects. Significantly higher CSF NOx levels were found in brain injury patients compared to control patients (19.7±13.7 vs. 6.5±2.3 μM; p=0.01), which persisted for 10-day period of observation. The serum and urine levels of NOx on admission were not statistically different (42.8±28.2 μM; 584.1±337.8 μmol/g Cr, respectively) from controls (36.8±14.8 μM; 819.7±356.0 μmol/g Cr), but tended to decrease during the disease course reaching the lowest level on day 6 (serum: 19.3±8.4 μM, urine: 300.4±111.9 μmol/g Cr). CSF levels of NOx correlated moderately with those in serum (p=0.001, R=0.5). Serum NOx concentrations correlated weakly with urine levels (p=0.04, R=0.3). There was no significant correlation between CSF NOx and urine NOx levels. In conclusion, patients suffering brain injury had increased NOx concentrations in CSF, which remained independent from other body fluid compartments. Serum and urinary NOx levels cannot be used as a reliable index to assess intrathecal NO production.
Original language | English (US) |
---|---|
Pages (from-to) | 1-7 |
Number of pages | 7 |
Journal | Journal of the Neurological Sciences |
Volume | 208 |
Issue number | 1-2 |
DOIs | |
State | Published - Apr 15 2003 |
Keywords
- Assay
- Body fluids
- Nitrate
- Nitric oxide
- Nitrite
- Vanadium
ASJC Scopus subject areas
- Aging
- Clinical Neurology
- Surgery
- Developmental Neuroscience
- Neurology
- General Neuroscience